XML 15 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Operating activities          
Net loss $ (1,352,824) $ (1,625,358) $ (5,132,914) $ (3,433,068) $ (5,058,426)
Adjustments to reconcile net loss to net cash used in operating activities:          
Amortization 5,311 4,265 16,291 13,368 17,633
Stock-based services expense 118,980 486,120 76,794 76,794
Forgiveness of subscription     9,051 9,050
Non-cash interest on convertible notes 30,800 39,508 152,045 76,359 115,867
Non-cash discount amortization on short-term notes convertible notes 233,223 298,605 611,020 943,427 1,242,031
Note issuance costs attributed to warrant liability and to convertible promissory note modification     38,119 38,119
Revaluation of premium conversion derivatives 6,265 (108,175) (371,831) 90,212 (17,962)
Revaluation of warrant liability 6,689 270,722 35,235 (12,707) 258,015
Loss on term notes extinguishments 350,914 1,314,487 350,914
Change in assets and liabilities:          
Prepaid expenses (26,814)      
Accounts payable and accrued expenses 278,686 171,115      
Prepaid expenses and other assets     1,768 46,677 46,677
Accounts payable     221,235
Accrued expenses     437,337 642,099 813,215
Net cash used in operating activities (699,684) (598,404) (2,229,207) (1,509,669) (2,108,073)
Investing activities          
Purchase of intangible assets (91,709) (55,000) (91,709)
Net cash used in investing activities (91,709) (55,000) (91,709)
Financing activities          
Proceeds from issuance of convertible promissory notes 328,429 432,849 675,705 1,004,134
Proceeds from issuance of warrants associated with convertible notes 336,571 442,151 440,919 777,490
Proceeds from issuance of warrants associated with short-term notes     61,496 61,496
Proceeds from issuance of common stock in connection with private placement 601,649   824,894
Proceeds from issuance of warrants in connection with private placement 223,351 288,106
Proceeds from unsecured loans 245,000 283,000 (50,000) (50,000)
Issuance costs related to short-term note     (3,030) (3,030)
Issuance costs related to convertible notes (9,779) (35,689) (45,468)
Issuance costs related to warrants (8,670) (31,920) (40,590)
Proceeds from advances related to private placement 40,000      
Issuance costs related to private placement (73,000)      
Net cash provided by financing activities 1,037,000 646,551 2,271,000 1,057,481 1,704,032
Net increase (decrease) in cash 337,316 (43,562) (13,207) (452,188) (495,750)
Cash at beginning of period 13,260 70,029 26,467 522,217 522,217
Cash at end of period 350,576 26,467 13,260 70,029 26,467
Supplemental non-cash financing and investing transactions:          
Bifurcation of premium conversion derivative related to convertible notes 128,525 168,384 213,961 342,486
Issuance of warrants in connection with convertible notes 117,280      
Stock value adjustment associated with intellectual license agreement   299      
Accrued issuance costs attributed to private placement and convertible notes 76,316 14,226      
Conversion of short-term notes and convertible promissory notes into common stock     2,063,361
Issuance of additional warrants in connection with short-term notes and convertible promissory notes modifications     829,378 117,280
Purchased intangible assets in accrued expenses $ 30,000 30,000
Common stock issued for the purchase of intangible assets     23,115 23,415
Accrued issuance costs related to private placement     173,067
Accrued issuance costs attributed to short-term promissory notes and convertible promissory notes     2,850 42,811 57,037
Accrued issuance costs attributed to warrant liability     $ 38,119 $ 38,119